BREAKING
NEW
20:45
Hegseth Doctrine Tests Civil-Military Norms Mid-Conflict
20:25
Mississippi Hanging Death Exposes Gaps in Rural Autopsy Law
20:05
Trump Cash Gifts to Aides Blur Line Between Personal and Official
09:45
Sapporo Shift Reveals Tariff Fault Lines in U.S. Brewing Economy
09:05
Hegseth Purges Reshape Pentagon's Civilian Command Layer
20:45
9/11 Toxic Air Cover-Up Docs Renew Pressure on EPA Chiefs
20:25
Pig Kidney Record Puts Xenotransplant Policy in Congress
20:05
Armed Attack on Ohio Governor Candidate Rattles Democrats
09:45
Pig Kidney Milestone Shifts U.S. Transplant Donor Debate
09:25
Canada Counter-Tariffs Squeeze U.S. Exporters on $20B Front
US Politics
Economy
Finance
Sports
Entertainment
Society
Health
Auto
Digital
World
Tools
CITIES
New York
Los Angeles
Chicago
Houston
Miami
Washington
San Francisco
Seattle
Boston
Dallas
Atlanta
Philadelphia
News
Zen
News
SECTIONS
US Politics
193 Articles
Senate & Congress
Democrats
Republicans
White House
World
205 Articles
Ukraine War
Middle East
NATO
China
UN & Diplomacy
Economy
103 Articles
Markets
Trade
Housing
Inflation
Tech
119 Articles
AI
Big Tech
Cybersecurity
Social Media
Electric Vehicles
Society
114 Articles
Immigration
Education
Crime
Environment
Cost of Living
Health
49 Articles
Medicare
Mental Health
Vaccines
Nutrition
Sports
166 Articles
NFL
NBA
MLB
NHL
F1
Climate
96 Articles
Net Zero
Renewable Energy
Extreme Weather
▶
YouTube News
Subscribe to our channel
⭐ Daily Horoscope
Contact the Newsroom
Results for “Ozempic”
11 results
Search
All
11
Health
7
Economy
4
Health
09 Jun 2026
Ozempic
Muscle Loss Fuels U.S. Drug Pipeline Race
Ozempic
and Wegovy-related muscle loss is spurring a major drug development race, with analysts predicting a $50+ billion market …
Economy
22 Jul 2026
Ozempic
Maker's Ad War Signals New Front in U.S. Weight-Loss Market
Novo Nordisk's suit against Eli Lilly could reshape pharma marketing rules
Health
07 Jun 2026
AI-Designed Vaccine Reaches U.S. Clinical Pipeline
AI-designed vaccine candidate enters U.S. clinical trial pipeline following development at the University of Cambridge, signaling…
Economy
06 Jul 2026
Weight-Loss Pill Boom Puts U.S. Insurers on Collision Course
Oral GLP-1 drugs enter market as coverage battles intensify across America
Health
12 Jun 2026
Wegovy Pill Form Puts U.S. Oral GLP-1 Market on Notice
Novo Nordisk's Wegovy oral tablet formulation of semaglutide intensifies competition in the U.S. GLP-1 weight-loss drug market, s…
Health
21 Jun 2026
Wegovy Pill Form Puts Pressure on U.S. Oral Drug Pipeline
Novo Nordisk's Wegovy pill formulation submission to the FDA is intensifying competition in the obesity drug market, prompting sc…
Economy
08 Jul 2026
Weight-Loss Jabs Reshape U.S. Consumer Spending Patterns
GLP-1 drug surge quietly disrupts retail, food, and beverage sectors
Health
20 Aug 2026
Weekly Insulin Shot Fuels U.S. Push to Simplify Diabetes Care
New once-weekly jab could ease burden for millions of Americans managing type 2 diabetes.
Economy
07 Aug 2026
Surprise Job Loss Dents Fed's Soft-Landing Confidence
August payroll miss complicates rate-cut timing ahead of September FOMC meeting
Health
14 Aug 2026
FDA's New Weight-Loss Pill Reshapes U.S. Obesity Drug Market
Eli Lilly's oral GLP-1 entry could pressure insurers and rivals as demand surges
Health
04 Aug 2026
MS Drug's U.S. Path Tests Medicare's Coverage Speed
Fampridine's NHS approval renews pressure on CMS to act on nerve-signal therapies
Topics:
NHS Policy
Ukraine War
NHS
Net Zero
Starmer
Zero
League
Artificial Intelligence
Ukraine
Senate
Russia
Champions
Champions League
Mental
Health
Renewable Energy
Final
Bill
Grid
Block
Target
Energy
Security
Council
Home
Search
Live
Sections
More